Home > Insider Trading > Filing (0001415889-24-027709)

Filing Details

Accession Number:: 0001415889-24-027709
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-26 16:15:07
Reporting Period:: 2024-11-22

Accepted Time:: 2024-11-26 16:15:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660334	Verrica Pharmaceuticals Inc.	VRCA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	200 Garrett Street, Suite S Charlottesville VA 22902		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-22	18,426,966	$0.00	26,278,094	No	4	P	Direct
Common Stock	Acquisiton	2024-11-22	4,494,382	$0.00	5,976,101	No	4	P	Indirect	See footnote
Common Stock	Disposition	2024-11-26	450,000	$0.00	25,828,094	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote
No	4	G	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrants (right to buy)	Acquisiton	2024-11-22	9,213,483	$0.00	9,213,483	$1.07
Common Stock	Series B Warrants (right to buy)	Acquisiton	2024-11-22	9,213,483	$0.00	9,213,483	$1.34
Common Stock	Series A Warrants (right to buy)	Acquisiton	2024-11-22	2,247,191	$0.00	2,247,191	$1.07
Common Stock	Series B Warrants (right to buy)	Acquisiton	2024-11-22	2,247,191	$0.00	2,247,191	$1.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,213,483	2024-11-22	2025-11-22	No	4	P	Direct
9,213,483	2024-11-22	2029-11-22	No	4	P	Direct
2,247,191	2024-11-22	2025-11-22	No	4	P	Indirect
2,247,191	2024-11-22	2029-11-22	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	891,870	Indirect	By trust
Common Stock	891,870	Indirect	By trust
Common Stock	891,870	Indirect	By trust
Common Stock	3,324,339	Indirect	By trust
Common Stock	256,634	Indirect	See footnote

Footnotes

The reported securities are included within 18,426,966 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock,a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
The shares are held by Mr. Manning jointly with his spouse.
The reported securities are included within 4,494,382 investment units purchased by BKB Growth Investments, LLC ("BKB") for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, one Series A warrant and one Series B warrant, each to purchase up to 2,247,191 shares of common stock.
The shares are held directly by BKB. The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.
These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.
The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.